Reduction in Serum High-Sensitivity C-Reactive Protein Favors Kidney Outcomes in Patients with Impaired Fasting Glucose or Diabetes.
Lili LiuBixia GaoJin-Wei WangChao YangShouling WuYuntao WuShuohua ChenQiuyun LiHuifen ZhangGuodong WangMin ChenMing-Hui ZhaoLuxia ZhangPublished in: Journal of diabetes research (2020)
Reduction in serum hs-CRP levels favors kidney outcomes in patients with impaired fasting glucose or diabetes.